The INT2ACT consotium brings together 9 universities, 6 research institutes, 7 companies, 1 research hospital and 2 non-profit organisations, creating a unique interdisciplinary and intersectoral training environment. Together, they provide advanced research training to 15 Doctoral Candidates, to develop innovative diagnostic and therapeutic approaches and drive Europe’s research in nucleic acid technologies forward.